Screener
Madrigal Pharmaceuticals, Inc. MDGL Business Segments — Product revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $364,252 | $212,802 | $675,589 | $350,052 |
| Cost of sales | (40,007) | (9,065) | (66,854) | (13,578) |
| Research and development: | ||||
| Compensation and benefit-related expenses | (14,991) | (8,469) | (30,088) | (17,504) |
| Stock-based compensation | (6,860) | (5,354) | (14,725) | (10,569) |
| Professional fees and other external expenses | (67,841) | (38,602) | (152,388) | (67,399) |
| Facility related and other internal expenses(1) | (1,486) | (1,656) | (2,669) | (2,781) |
| Selling, general and administrative: |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s business segments — product revenue, net?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported business segments — product revenue, net of $364.25M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s business segments — product revenue, net changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s business segments — product revenue, net increased by 71.2% year-over-year, from $212.8M to $364.25M.
- What does business segments — product revenue, net mean?
- This represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, allowances, and rebates. It serves as the primary indicator of market adoption and commercial success for the company's therapeutic offerings.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s business segments — product revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude